CDTX – cidara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Halper Sadeh LLC Encourages GIFI, MOVE, RMBI, CDTX Shareholders to Contact the Firm to Discuss Their Rights
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-NUVSF, NDTAF, THS, and CDTX
Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025 [Forbes]
Cidara Therapeutics (NASDAQ:CDTX) had its "neutral" rating reaffirmed by analysts at Guggenheim.
Form SC 14D9 Cidara Therapeutics, Filed by: Cidara Therapeutics, Inc.
Form SC TO-T Cidara Therapeutics, Filed by: Merck & Co., Inc.
Form SCHEDULE 13D/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Commodore Capital LP
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Paradigm Biocapital Advisors LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.